May 16, 2019
U.S. FDA Renews DILIsym Software Licenses
U.S. FDA Remains Committed to Streamline & Accelerate Drug Development using Model-Informed Drug Development (MIDD) technology RESEARCH TRIANGLE PARK, N.C.–(BUSINESS…
Pharmaceuticals, Biotechnology and Life Sciences
U.S. FDA Remains Committed to Streamline & Accelerate Drug Development using Model-Informed Drug Development (MIDD) technology RESEARCH TRIANGLE PARK, N.C.–(BUSINESS…
Access to Resero’s TurboToxicology™ will provide faster delivery of high-quality toxicology reports WILMINGTON, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24CRL&src=ctag" target="_blank"gt;$CRLlt;/agt; lt;a href="https://twitter.com/hashtag/LIFEatCRL?src=hash" target="_blank"gt;#LIFEatCRLlt;/agt;–Charles…
Accepted abstracts highlight additional data from phase 3 ARIEL3 clinical trial, genomic data from phase 2 TRITON2 clinical trial, and…
Yong Dai, Ph.D., Promoted to Chief Technology Officer Tim Adams Joins Board of Directors; Francois Nader, M.D., Role Expanded to…
̶ ICON-2 program targets Tissue Factor (TF) with potential broad impact in oncology ̶ ̶ Exelixis will make upfront payment…
–Company strengthens board of directors and scientific advisory board with appointments of Mike Raab and Benjamin Cravatt– SAN FRANCISCO–(BUSINESS WIRE)–Tempest…
PRINCETON, N.J.–(BUSINESS WIRE)–Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, announced today…
New Category Offers Surgeons Strong, Secure Fixation and “Biologically Friendly” Approach to Restoring Patient Stability and Mobility with No Permanent…
– Company Enters into Commercial Supply Agreement for AR101 – BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company…
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., is proud to announce that…